Education
About Us
Working with TipRanks
Follow Us
Emcure Pharmaceuticals Limited (IN:EMCURE)
:EMCURE
See the Price Targets and Ratings of:
EMCURE Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
J.P. Morgan
₹1,580→₹1,440
Hold
34.13%
Upside
Reiterated
02/07/25
Jefferies
₹1,730→₹1,650
Buy
53.70%
Upside
Reiterated
02/06/25
Kotak Mahindra
₹1,680
Buy
56.49%
Upside
Reiterated
12/27/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
J.P. Morgan
₹1,580→₹1,440
Hold
34.13%
Upside
Reiterated
02/07/25
Jefferies
₹1,730→₹1,650
Buy
53.70%
Upside
Reiterated
02/06/25
Kotak Mahindra
₹1,680
Buy
56.49%
Upside
Reiterated
12/27/24
Best Analysts Covering Emcure Pharmaceuticals Limited
1 Month
xxx
Success Rate
1/3 ratings generated profit
Average Return
-10.10%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 33.33% of your transactions generating a profit, with an average return of -10.10% per trade.
3 Months
xxx
Success Rate
1/3 ratings generated profit
Average Return
-16.00%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -16.00% per trade.
1 Year
Success Rate
2/3 ratings generated profit
Average Return
-0.10%
reiterated a buy rating 17 days ago
Copying Alok Dalal's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -0.10% per trade.
2 Years
xxx
Success Rate
2/3 ratings generated profit
Average Return
-0.10%
reiterated a xxx
rating 17 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of -0.10% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
EMCURE Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
May 25
Strong Buy
0
0
0
0
Buy
1
2
3
4
Hold
0
0
1
2
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
2
4
6
Each month's total comprises the sum of three months' worth of ratings.
EMCURE Stock Forecast FAQ
What is IN:EMCURE’s average 12-month price target, according to analysts?
Based on analyst ratings, Emcure Pharmaceuticals Limited’s 12-month average price target is 1,590.00.
What is IN:EMCURE’s upside potential, based on the analysts’ average price target?
Emcure Pharmaceuticals Limited has 48.11% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Emcure Pharmaceuticals Limited a Buy, Sell or Hold?
Emcure Pharmaceuticals Limited has a consensus rating of Moderate Buy, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is Emcure Pharmaceuticals Limited’s share price target?
The average share price target for Emcure Pharmaceuticals Limited is 1,590.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,680.00 ,and the lowest forecast is ₹1,440.00. The average share price target represents 48.11% Increase from the current price of ₹1,073.55.
The highest analyst share price target is ₹1,680.00 ,and the lowest forecast is ₹1,440.00. The average share price target represents 48.11% Increase from the current price of ₹1,073.55.
What do analysts say about Emcure Pharmaceuticals Limited?
Emcure Pharmaceuticals Limited’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of Emcure Pharmaceuticals Limited?
To buy shares of IN:EMCURE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.